BTESF

Biotest AG

BTESF · — · Category unavailable · Founded 1963

Karkhanjat Darupakhsh Company is the largest pharmaceutical company in Iran, 74% of whose shares belong to Social Security Investment Company (Shasta). Daropakhsh Pharmaceuticals Company operates in various fields of human medicine, veterinary medicine, biology, herbal medicine and health medicine.[1] The subject of the company's activity is the production, preparation and import of human medicines, veterinary medicine, milk powder, baby food, food, medical supplies, cosmetics, laboratory and their distribution and sale throughout the country, as well as the purchase and sale of raw materials and providing Packaging services. Established in 1963 under the name of Daropakhsh pharmaceutical factory and producing 20 types of drugs including tablets and syrups and injectable products under license 1978 under the ownership of the Ministry of Health and production of generic products 1980, transformation in the organizational structure 1992 under the ownership of the Social Security Organization 1993 change from private to public shares In 1998, one of the subsidiaries of Darupakhsh Company named Karkhanjat Darupakhsh Company (public shares) Darou Pakhsh Holding Company (Persian: شرکت کارخانجات داروپخش, Shirkæt-e Karxanujat-e Darvipaxesh, lit. drug distribution company) is a major pharmaceutical company in Iran. The company is majority-owned by the Social Security Organization of Iran. The company manufactures, distributes, imports and exports finished products and pharmaceutical raw materials. Darou Pakhsh has an annual turnover of US$400m and claims to have the largest research and development operation of any Iranian drug firm. The company formed a plasmapheresis joint venture with a German medical firm, Biotest AG, in early 2004. Darou Pakhsh is listed on the Tehran Stock Exchange.

Current Price
—
Market Cap
—
Return Since Last Split
—
Last Split
Jul 15, 2015
Total Splits
1
Cumulative Multiple
3×

What If You Bought BTESF Earlier?

Investment
Purchase Date (Before Split)
Worth Today
—
300 shares · 3×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth from that date to today.

Split DatePrice BeforeRatioSplit MultipleCumulative
Jul 15, 2015—3-for-13×3×

Biotest AG Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover all 1 recorded split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

Biotest AG's latest record in the split calendar is a 3-for-1 forward split effective 2015-07-15.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.